Russian Medical Inquiry
(RMZh. Meditsinskoe Obozrenie) ISSN 2587-6821 (Print), 2686-9918 (Online)

Local conjunctival AL amyloidosis

VAK

Scopus

E-libraryDimensions

russian citation indexULRICHS

roaddoaj

CyberleninkaGoogle Scholar

vinitiResearch4life

MendeleyScilit

РГБWhite list




Open accessCrossrefAntiplagiat

RMJ.ru




DOI: 10.32364/2311-7729-2026-26-1-10

E.V. Reznik1,2, T.L. Nguyen3, Ya.V. Parmon4, S.E. Arakelov5, L.M. Mikhaleva6

1Pirogov Russian National Research Medical University, Moscow, Russian Federation

2Academician G.M. Savel'eva City Clinical Hospital No. 31, Moscow, Russian Federation

3Central Military Hospital No. 108, Hanoi, Vietnam

4Helmholtz National Medical Research Center, Moscow, Russian Federation

5V.P. Demikhov City Clinical Hospital, Moscow, Russian Federation

6Research Institute of Human Morphology named after Academician A.P. Avtsyn,   Academician B.V. Petrovskiy Russian Scientific Center of Surgery, Moscow,   Russian Federation

Amyloidosis is a group of diseases characterized by deposition of abnormal glycoprotein (i.e., amyloid) in tissues leading to structural changes and dysfunction of target organs. Amyloidosis can be both systemic (damage to two or more organ systems) or, less often, local (i.e. localized within a morphological unit). Amyloidosis may affect any organ. Its progression is extremely unpredictable, and the disease can result in a poor outcome. Thus, any practitioner, including an ophthalmologist, should consider the condition as a part of differential diagnosis, and ensure timely appropriate routing and therapy of a patient. Ocular amyloidosis occurs in 4% of all patients with local amyloidosis. Conjunctival amyloidosis is poorly reported, as it is very rare in clinical practice. The disease may be local without association with other systemic manifestations. The authors present a clinical case report of histologically verified amyloidosis associated with synthesis of free light chains of immunoglobulins in both eyes (first, in the right eye and, then, in the left one) without damage to other organs. The patient underwent a surgical intervention for local removal of the affected tissue and an examination to exclude a potential risk of systemic amyloidosis.

Keywords: amyloidosis, local amyloidosis, conjunctival amyloidosis, ocular amyloidosis, AL amyloidosis, systemic amyloidosis.

For citation: Reznik E.V., Nguyen T.L., Parmon Ya.V., Arakelov S.E., Mikhaleva L.M. Local conjunctival AL amyloidosis. Russian Journal of Clinical Ophthalmology. 2026;26(1):65–70 (in Russ.). DOI: 10.32364/2311-7729-2026-26-1-10

Локальный AL-амилоидоз конъюнктивы

ABOUT THE AUTHORS:

Elena V. Reznik — Dr. Sc. (Med.), Assistant Professor, Head of the Department of Propaedeutics of Internal Diseases No. 2, Institute of Clinical Medicine, Pirogov Russian National Research Medical University; 1, bld. 6, Ostrovityanov str., Moscow, 117513, Russian Federation; Cardiologist, Therapist, Specialist in Functional and Ultrasound Diagnostics, Academician G.M. Savel'eva City Clinical Hospital No. 31; 42, Lobachevskyi str., Moscow, 119415, Russian Federation; ORCID iD 0000-0001-7479-418X

Nguyen Thanh Luan — C. Sc. (Med.), Interventional Cardiologist, Department of Cardiovascular Diagnostics and Intervention, Central Military Hospital No. 108; 1, Tran Hung Dao Street, Hanoi, 113000, Vietnam; ORCID iD 0000-0002-8856-4542

Yanina V. Parmon — C. Sc. (Med.), Ophthalmologist, Head of the Ophthalmological Department for Treatment of Oncological Eye Diseases, Helmholtz National Medical Research Center; 14/19, Sadovaya-Chernogryazskaya str., Moscow, 105062, Russian Federation; ORCID iD 0009-0003-1320-8134

Sergey E. Arakelov — Dr. Sc. (Med.), Oncologist, Chief Physician of V.P. Demikhov City Clinical Hospital; 1/1, Velozavodskaya str., Moscow, 115280, Russian Federation; ORCID iD 0000-0003-3911-8543

Lyudmila M. Mikhaleva — Dr. Sc. (Med.), Professor, Corresponding Member of the Russian Academy of Sciences, Vice-President of the Russian Society of Pathologists, Director of Research Institute of Human Morphology named after Academician A.P. Avtsyn, Academician B.V. Petrovskiy Russian Scientific Center of Surgery; 3, Tsyurupa str., Moscow, 117418, Russian Federation; ORCID iD 0000-0003-2052-914X

Contact information: Nguyen Thanh Luan, e-mail: truongthianh0302@gmail.com

Financial Disclosure: no authors have a financial or property interest in any material or method mentioned.

There is no conflict of interest.

Received 09.10.2024.

Revised 05.11.2024.

Accepted 28.11.2024.

References
1. Резник Е.В., Нгуен Т.Л., Степанова Е.А. и др. Амилоидоз сердца: взгляд терапевта и кардиолога. Архивъ внутренней медицины. 2020;10:430–457. DOI: 10.20514/2226-6704-2020-10-6-430-457Reznik E.V., Nguyen T.L., Stepanova E.A. et al. Cardiac Amyloidosis: Internist and Cardiologist Insight. The Russian Archives of Internal Medicine. 2020;10(6):430–457 (in Russ.). DOI: 10.20514/2226-6704-2020-10-6-430-457
2. Резник Е.В., Нгуен Т.Л., Устюжанин Д.В. и др. «Красные флаги» диа­гностики инфильтративных заболеваний сердца. Российский кардиологический журнал. 2023;28:5259. DOI: 10.15829/1560-4071-2023-5259 Reznik E.V., Nguyen T.L., Ustyuzhanin D.V. et al. Red flags to diagnose infiltrative cardiomyopathies. Russian Journal of Cardiology. 2023;28(1S):5259 (in Russ.). DOI: 10.15829/1560-4071-2023-5259
3. Benson M.D., Buxbaum J.N., Eisenberg D.S. et al. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid. 2018;25:215–219. DOI: 10.1080/13506129.2018.1549825
4. Резник Е.В., Степанова E.A., Нгуен Т.Л. и др. Ретроспективный анализ поражения сердечно-сосудистой системы у больных системным амилоидозом. Кардиоваскулярная терапия и профилактика. 2021;20(1):2496.Reznik E.V., Stepanova E.A., Nguyen T.L. et al. Retrospective analysis of cardiovascular involvement in patients with systemic amyloidosis. Cardiovascular Therapy and Prevention. 2021;20(1):2496 (in Russ.).
5. Резник Е.В., Гусева А.Л., Ясновская А.А. и др. Двусторонняя вестибулопатия и сенсоневральная тугоухость у пациента с некротической ксантогранулемой, множественной миеломой и амилоидозом. Вестник оториноларингологии. 2024;89(2):82–87. DOI: 10.17116/otorino20248902182Reznik E.V., Guseva A.L., Yasnovskaya A.A. et al. Bilateral vestibulopathy and sensorineural hearing loss in necrobiotic xanthogranuloma, multiple myeloma and amiloidosis. Russian Bulletin of Otorhinolaryngology. 2024;89:82–87 (in Russ.). DOI: 10.17116/otorino20248902182
6. Hazenberg B.P.C. Amyloidosis: A Clinical Overview. Rheum Dis Clin North Am. 2013;39:323–345. DOI: 10.1016/j.rdc.2013.02.012
7. Gean-Marton A.D., Kirsch C.F., Vezina L.G. et al. Focal amyloidosis of the head and neck: evaluation with CT and MR imaging. Radiology. 1991;181:521–525. DOI: 10.1148/radiology.181.2.1924798
8. Tao P.P., Rameev V.V., Rameeva A.S. et al. Diagnosis and treatment of localized AL-amyloidosis. CPT. 2019;28:39–46. DOI: 10.32756/0869-5490-2019-3-39-46
9. Ермилова В.В., Серов В.В. Место амилоидоза глаза среди различных форм амилоидоза. Архив патологии. 1994;4:9–14.Ermilova V.V., Serov V.V. The place of ocular amyloidosis among various forms of amyloidosis. Archives of Pathology. 1994;4:9–14 (in Russ.).
10. Garg N., Diwaker P., Gaur J.H. et al. Conjunctival Amyloidosis: A Report of Two Cases with Review of Literature — 2000–2020. J Microsc Ultrastruct. 2022;10:214–218. DOI: 10.4103/jmau.jmau_88_20
11. Mora-Horna E.R., Rojas-Padilla R., López V.G. et al. Ocular adnexal and orbital amyloidosis: a case series and literature review. Int Ophthalmol. 2016;36:281–298. DOI: 10.1007/s10792-015-0138-7
12. Suesskind D., Ziemssen F., Rohrbach J.M. Conjunctival amyloidosis — clinical and histopathologic features. Graefes Arch Clin Exp Ophthalmol. 2015;253:1377–1383. DOI: 10.1007/s00417-015-2932-3

License Creative Commons
This work is licensed under a Creative Commons «Attribution» 4.0 License.


Previous article
Next article